Growth Metrics

Fulgent Genetics (FLGT) Other financing activities (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Other financing activities for 8 consecutive years, with $447000.0 as the latest value for Q4 2025.

  • Quarterly Other financing activities rose 84.71% to $447000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2025, up 4.73% year-over-year, with the annual reading at $3.0 million for FY2025, 4.73% up from the prior year.
  • Other financing activities hit $447000.0 in Q4 2025 for Fulgent Genetics, up from $357000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $2.9 million in Q3 2021 to a low of $39000.0 in Q2 2021.
  • Historically, Other financing activities has averaged $731684.2 across 5 years, with a median of $494000.0 in 2022.
  • Biggest YoY gain for Other financing activities was 1017.95% in 2022; the steepest drop was 82.09% in 2022.
  • Year by year, Other financing activities stood at $2.9 million in 2021, then crashed by 89.16% to $316000.0 in 2022, then soared by 252.53% to $1.1 million in 2023, then crashed by 78.28% to $242000.0 in 2024, then soared by 84.71% to $447000.0 in 2025.
  • Business Quant data shows Other financing activities for FLGT at $447000.0 in Q4 2025, $357000.0 in Q3 2025, and $345000.0 in Q2 2025.